SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-074199
Filing Date
2020-06-17
Accepted
2020-06-17 16:46:30
Documents
3
Period of Report
2020-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022844d1_8k.htm 8-K 21460
2 EXHIBIT 99.1 tm2022844d1_ex99-1.htm EX-99.1 9653
3 GRAPHIC image_001.jpg GRAPHIC 4749
  Complete submission text file 0001104659-20-074199.txt   39167
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 20970262
SIC: 8731 Services-Commercial Physical & Biological Research